just saw news Bioalpha appointed by Langkawi Development Authority to develop and manage 8-acre agro park in langkawi.. will be ready in 3 years.. new revenue stream for Bioalpha?
maybe potential to be new tourist hot spot in langkawi..

The Edge: Bioalpha appointed to develop agro park in Langkawi

https://theedgemalaysia.com/node/692592

KUALA LUMPUR (Dec 4): Bioalpha Holdings Bhd said that its wholly-owned subsidiary has been appointed by the Langkawi Development Authority (Lada) to develop and operate a 7.98-acre agro park in Bandar Padang Mat Sirat, Langkawi.

“Bioalpha Wellness Sdn Bhd’s scope is to develop the project and upon completion, will undertake the management and operations of the park,” the integrated health supplement group said in a filing on Monday.

As the owner of the land, Lada — an agency under the Ministry of Finance tasked to propel the tourism economy of Langkawi — is granting Bioalpha Wellness rights of land use for 30 years, said Bioalpha.

Bioalpha Wellness, meanwhile, will provide Lada with a yearly fixed fee and quit rent and assessment. The company will also provide an estimated investment of at least RM15 million to be funded by internally generated funds and bank borrowings.

As of December 2022, Bioalpha’s cash balances stood at RM39.8 million.

Bioalpha said development of the agro park will commence immediately, with the opening targeted in three years.

“Bioalpha plans to develop the park showcasing the integrated facility encompassing the full spectrum of the supply chain, from herbal farming, research and development to product processing.

“One of the park’s attractions will be the herbal garden featuring a smart greenhouse with over 300 high-value crop varieties, where visitors can actively participate in planting and harvesting activities,” the company said in a statement, adding that the park is also capable of catering to international meetings, incentives, conferences, and exhibitions (Mice) events related to herbal farming and agriculture.

Shares in Bioalpha closed half a sen or 5.56% lower to 8.5 sen on Monday, giving the group a market capitalisation of RM119.55 million. Year to date, the counter has declined 22.73%.

----

The Star: Bioalpha to develop an 8-acre agro park in Langkawi

https://www.thestar.com.my/business/business-news/2023/12/04/bioalpha-to-develop-an-8-acre-agro-park-in-langkawi

KUALA LUMPUR: Bioalpha Holdings Bhd’s wholly-owned subsidiary, Bioalpha Wellness Sdn Bhd has entered into a manage and operate agreement with the Langkawi Development Authority (LADA) to develop, manage, and operate an agro park in Langkawi, Kedah (Langkawi Agro Park).

LADA is an agency under the Ministry of Finance, tasked to propel the tourism economy of Langkawi to advance the island to become a world-renowned tourist destination.

The integrated health supplement company, in a statement, said the proposed park would be built on an 8-acre land situated in a prime location at Padang Matsirat, approximately 1 km away from the Langkawi International Airport.

Under the agreement, LADA as the landowner, shall grant Bioalpha the land use rights for 30 years effective from the signing date. Bioalpha’s scope is to develop the agro park and upon completion, it will undertake the management and operations of the park.

Bioalpha plans to develop the park showcasing the integrated facility encompassing the full spectrum of the supply chain, from herbal farming, and R&D to product processing.

“Development of the park is slated to commence immediately, with the park opening targeted in two years.

“The estimated investment of at least RM15mil by Bioalpha will be funded by internally generated funds and bank borrowings. As at Dec 31, 2022, Bioalpha has robust cash balances of RM39.8mil,” it said.

“We are eager to commence works and expect contributions from the park starting in 2027. With a diverse range of attractions, we are confident that the park will be enthusiastically embraced by the public,” Bioalpha managing director William Hon said.

He said the development enabled the group to broaden its revenue streams from various sources such as admission fees to the park, commercialisation of more than 100 high-value herbal products packaged in Langkawi-inspired branding, in addition to in-park collections from the sale of products, and food and beverages (F&B).

“At the same time, we aim to tap into our agricultural expertise to promote and educate about Malaysia’s high-value herbs to both local and international tourists. Our goal is to create a holistic edutainment experience for visitors, where they can gain greater cultural and learning awareness through the activities,” Hon said.

Encouraging news on GFM.. Menang award.

Frost & Sullivan Best Practices Recognizes Disruptive Companies with Prestigious Industry Awards

https://www.prnewswire.com/news-releases/frost--sullivan-best-practices-recognizes-disruptive-companies-with-prestigious-industry-awards-301313441.html

SINGAPORE, June 16, 2021 /PRNewswire/ -- Frost & Sullivan Best Practices Awards honor organizations that have accomplished innovative or disruptive breakthroughs and have continually demonstrated excellence.

"Frost & Sullivan's Best Practices Awards are presented to companies that inspire growth in their industries. We recognize those who are paving the way for new areas of growth in industries, society, and the world at large. They are the game changers," said Sapan Agarwal, Senior Vice President, Best Practices, Frost & Sullivan.

Frost & Sullivan follows its proprietary, measurement-based methodology, combined with extensive research, in-depth interviews, analyses, and benchmarking, to shortlist deserving companies in each category. With real-time performance indicators, such as market share, revenue growth, customer acquisitions, product/service value, and technology innovation, forming the backbone of the selection process, the winners represent the best of the best in the Asia-Pacific region.

The ten awards are segmented into regional and national categories. Frost & Sullivan congratulates all recipients of the Asia-Pacific Best Practices Awards.

2021 Malaysia Facilities Management Competitive Strategy Leadership Award
GFM Services Berhad

Wah.. New platform to sell health supplements.. Bioalpha form JV to supply health products/services to 201 Felda supermarkets, reaching 2.6 million Felda settlers.. Will see increase in sales?

Bioalpha inks deal to supply health products to 201 Felda's D'Mart stores
https://www.nst.com.my/business/2021/05/692758/bioalpha-inks-deal-supply-health-products-201-feldas-dmart-stores

KUALA LUMPUR: Health supplement company Bioalpha Holdings Bhd (BHB), through its wholly-owned subsidiary, Botanical Distribution Sdn Bhd (BDSB), signed a joint venture (JV) agreement with RS Unggul Sdn Bhd (RSU) for the issuance of 4.9 million new ordinary shares in RS Bio Sdn Bhd (RBSB) to GV Global Venture Sdn Bhd (GVG), an associate company of RSU.

RBSB is a JV company between BDSB and RSU.

Upon completion of the allotment of new RBSB shares, BDSB shall hold 51 per cent stake in RBSB, while the remaining 49 per cent stake is held by GVG.

RSU is principally involved in the manufacturing and supply of agriculture and food products, including but not limited to groceries, pharmaceutical products, medicines and original equipment manufacturer (OEM) health supplements.

The company currently has about RM20 million supply contracts on hand, with the potential to secure up to RM50 million worth of new contracts in the next 12 months.

One of RSU's major customers is Koperasi Permodalan Felda Malaysia Bhd (KPF), the cooperative controlled by Federal Land Development Authority (Felda) settlers.

KPF owns and operates a chain of 201 D'Mart convenience stores nationwide located within Felda settlements, with 187 outlets in Peninsular Malaysia and 14 outlets in Sabah.

These shops serve some 2.6 million Felda settlers and their families, comprising approximately 200,000 households.

Further, RBSB will therefore undertake the supply of a wide range of over-the-counter (OTC) products, health supplements, functional foods and grocery offerings to RSU's customers, including KPF's 201 D'mart stores.

With orders firmly in hand following the JV agreement, BHB shall immediately manufacture and supply various health supplement and functional food products under original design manufacturing (ODM) basis, including Tongkat Ali coffee, Choco Malt and Royal Milk Tea premixes.

BHB managing director William Hon said the tie up with RSU will enhance the range of offerings, including those supplied to D'Mart convenience shops.

"The JV arrangement aligns both companies to better serve the people of Felda, leveraging on each party's expertise and experience to grow both businesses.

"As RSU is an existing supplier to KPF, we shall leverage on the company's established network to carry and introduce health food and supplement offerings to the Felda settlers," he said in a statement today.

He said for BHB, this collaboration will broaden the company's distribution reach to D'Mart stores.

"As we progress along, we look forward to serving the Felda settlers while positioning the Group for future success," he said.

Halo newbie here.. I smell opportunity in Bioalpha ICPS.. The Warrants Specialist said ICPS got chance trade higher than warrant.. Article below. Any input from the taikor expert here?


Bioalpha Holdings Berhad recently completed a rights issues of ordinary share and ICPS (Irredeemable Convertible Preference Share). The rights issue was a relatively small one as it was only offered to shareholders based on a ratio of 1 for 15 (for the mother share at 20 sen per share) and 1 for 6 (for the ICPS at 2 sen per share). Based on the company announcement last week, the rights issue was oversubscribed by 55% for the mother share and 208% for the ICPS.

BIOHLDG’s ICPS is a warrant-like instrument that also allows its holders to “exercise” the convertible preference share into the mother share by paying up in cash. The conversion price of the ICPS is 22 sen and its holders can either convert to mother share by tendering 11 units of ICPS or 1 unit of ICPS plus 20 sen in cash. The latter method of conversion turns ICPS into a warrant with an exercise price of 20 sen. Due to the low issue price of the ICPS, cash conversion is most likely adopted unless the ICPS falls below 2 sen after trading.

Due to the market weakness recently, the subscription rights of the mother share (BIOHLDG-OR) and ICPS (BIOHLDG-PR) did not attract too much interest. BIOHLDG-OR ended at a slight “exercise discount” to the mother share which is normally the case with subscription rights. However, BIOHLDG-PR ended its brief trading period on 3 May 2021 at 4 sen while the company’s warrant BIOHLDG-WA, which has a much shorter tenure and higher exercise price than the ICPS, closed at 10 sen on the same day.

The table below are the summary of the profile of the two securities with the price of the ICPS (BIOHLDG-PA) implied from the closing price of BIOHLDG-PR by adding 2 sen subscription price. It should be noted that the price of the mother share and warrant has retreated 6.7% and 15% from 3 May 2021.

BIOHLDG-WA BIOHLDG-PA
Warrant Price : RM0.085 RM0.060
Mother Share Price : RM0.210 RM0.210
Exercise/Conversion Price : RM0.220 RM0.200 or 11 for 1
Expiry Date : 5/1/2022 26/5/2026*
Premium : 45.2% 23.8%
Gearing : 2.47x 3.5x
Historical Volatility : 57.4% 57.4%
Warrant’s Implied Volatility : 137.4% 21.0%
Delta : 0.70 0.76
Effective Gearing : 1.72x 2.67x

Estimated issue date

If the mother share price remains stable, BIOHLDG-PA should trade at a higher price than BIOHLDG-WA. We will know on 28 May when the ICPS starts trading to find out.

Source: http://www.warrants.com.my/english/index.php/english/17-malaysia-warrants/1963-biohldg-new-warrant-like-icps-better-than-biodg-wa